Zhou Jiang

5PUBLICATIONS
28CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 04, 2023
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.

Paul Koller, Natalia Baran, Karine Harutyunyan

|Apr 06, 2022
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function.

Xixi Zhao, Yongkun Wei, Yu-Yi Chu

|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.

Heng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang

Pageof 1